← All trials
NCT07256782
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 24, 2025
- Primary completion
- Oct 31, 2026
- Completion date
- May 31, 2028
- First posted
- Dec 1, 2025
- Last posted
- Dec 1, 2025
- Enrollment
- 444
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Qilu Pharmaceutical Co., Ltd.Lead sponsor
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.